Cyclosporine trough levels comparison with AUC during conversion to microemulsion formulation (''Neoral'').

被引：0
|
作者：
Heifets, M
Sellers, P
Sallas, W
Browne, B
Samuels, LA
Cooney, G
机构：
[1] TEMPLE UNIV HOSP & MED SCH, DEPT MED, PHILADELPHIA, PA 19140 USA
[2] TEMPLE UNIV HOSP & MED SCH, DEPT SURG, PHILADELPHIA, PA 19140 USA
[3] TEMPLE UNIV HOSP & MED SCH, DEPT PHARM, PHILADELPHIA, PA 19140 USA
[4] SANDOZ RES INST, E HANOVER, NJ USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A3322 / A3322
页数：1
相关论文
共 50 条
  • [21] Absorption profiling of cyclosporine microemulsion (Neoral) during the first 2 weeks after renal transplantation
    Keown, P
    Cole, E
    Landsberg, D
    Shapiro, J
    Halloran, P
    Muirhead, N
    Lawen, J
    Zaltzman, J
    Murphy, GF
    Tan, A
    Balshaw, R
    Primmett, D
    Ngai, J
    Hendricks, L
    DuBois-Laviolette, A
    TRANSPLANTATION, 2001, 72 (06) : 1024 - 1032
  • [22] Cardiovascular risk factors after liver transplantation (LT): Comparison of microemulsion cyclosporine (neoral), conventional cyclosporine (CSA), and tacrolimus.
    Canzanello, VJ
    Taler, SJ
    Textor, SC
    Schwartz, L
    Wiesner, RH
    Porayko, MK
    Krom, RA
    TRANSPLANTATION, 1999, 67 (07) : S200 - S200
  • [23] ENHANCED ABSORPTION OF NEW ORAL CYCLOSPORINE MICROEMULSION FORMULATION, NEORAL, IN LIVER-TRANSPLANT RECIPIENTS WITH EXTERNAL BILIARY DIVERSION
    TRULL, AK
    TAN, KKC
    TAN, L
    ALEXANDER, GJM
    JAMIESON, NV
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2977 - 2978
  • [24] Comparison of clinical effects, trough and peak levels between branded and generic formulation of Cyclosporine in stable psoriatic patients
    Buligan, Cinzia
    Pinzani, Caterina
    Cimarosti, Rossella
    Stinco, Giuseppe
    Baraldo, Massimo
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2020, 155 (04): : 452 - 458
  • [25] Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporine
    Freise, CE
    Galbraith, CA
    Nikolai, BJ
    Ascher, NL
    Lake, JR
    Stock, PG
    Roberts, JP
    TRANSPLANTATION, 1998, 65 (07) : 995 - 997
  • [26] Comparison of monitoring trough and peak cyclosporine levels in heart transplantation
    Ballesteros, S
    Lage, E
    Villa, M
    Ordóñez, A
    Borrego, JM
    Gutierrez, E
    Hernández, A
    Hinojosa, R
    Cisneros, JM
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 727 - 728
  • [27] Comparison of cyclosporine trough levels measured by two different assays
    Lehneman, JB
    Smallwood, GA
    PHARMACOTHERAPY, 2004, 24 (10): : 1466 - 1467
  • [28] Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral)
    Jaksch, P
    Kocher, A
    Neuhauser, P
    Sarahrudi, K
    Seweryn, J
    Wisser, W
    Klepetko, W
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (08): : 1076 - 1080
  • [29] Two hours post-dose determination of cyclosporine microemulsion (sandimum neoral) levels in the treatment of rheumatoid arthritis (RA)
    Cruz, J
    Gómez, A
    Sánchez, J
    Miguelez, R
    Del Blanco, J
    Geli, C
    Ibañez, J
    Lozano, A
    Sanchez, J
    Molina, X
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 433 - 433
  • [30] Kidney function after 1:1 conversion to the cyclosporine microemulsion formulation in children with liver allografts
    Laine, J
    Hoppu, K
    Jalanko, H
    Ronnholm, K
    Holmberg, C
    TRANSPLANTATION, 1997, 63 (12) : 1768 - 1772
12345